全文获取类型
收费全文 | 10030篇 |
免费 | 936篇 |
国内免费 | 387篇 |
出版年
2024年 | 7篇 |
2023年 | 43篇 |
2022年 | 156篇 |
2021年 | 258篇 |
2020年 | 226篇 |
2019年 | 280篇 |
2018年 | 332篇 |
2017年 | 272篇 |
2016年 | 375篇 |
2015年 | 552篇 |
2014年 | 642篇 |
2013年 | 676篇 |
2012年 | 902篇 |
2011年 | 851篇 |
2010年 | 551篇 |
2009年 | 507篇 |
2008年 | 624篇 |
2007年 | 574篇 |
2006年 | 475篇 |
2005年 | 478篇 |
2004年 | 487篇 |
2003年 | 435篇 |
2002年 | 382篇 |
2001年 | 271篇 |
2000年 | 218篇 |
1999年 | 174篇 |
1998年 | 78篇 |
1997年 | 68篇 |
1996年 | 47篇 |
1995年 | 36篇 |
1994年 | 41篇 |
1993年 | 19篇 |
1992年 | 40篇 |
1991年 | 39篇 |
1990年 | 29篇 |
1989年 | 17篇 |
1988年 | 27篇 |
1987年 | 12篇 |
1986年 | 10篇 |
1985年 | 14篇 |
1984年 | 8篇 |
1982年 | 8篇 |
1980年 | 8篇 |
1979年 | 8篇 |
1978年 | 9篇 |
1976年 | 9篇 |
1975年 | 7篇 |
1973年 | 10篇 |
1971年 | 8篇 |
1967年 | 8篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
111.
Hyoung-Min Park HuiSu Kim Dong Wook Kim Jong-Hyuk Yoon Byung-Gyu Kim Je-Yoel Cho 《BMB reports》2020,53(12):664
Breast cancer is one of the most frequently diagnosed cancers. Although biomarkers are continuously being discovered, few specific markers, rather than classification markers, representing the aggressiveness and invasiveness of breast cancer are known. In this study, we used samples from canine mammary tumors in a comparative approach. We subjected 36 fractions of both canine normal and mammary tumor plasmas to high-performance quantitative proteomics analysis. Among the identified proteins, LCAT was selectively expressed in mixed tumor samples. With further MRM and Western blot validation, we discovered that the LCAT protein is an indicator of aggressive mammary tumors, an advanced stage of cancer, possibly highly metastatic. Interestingly, we also found that LCAT is overexpressed in high-grade and lymphnode-positive breast cancer in silico data. We also demonstrated that LCAT is highly expressed in the sera of advanced-stage human breast cancers within the same classification. In conclusion, we identified a possible common plasma protein biomarker, LCAT, that is highly expressed in aggressive human breast cancer and canine mammary tumor. 相似文献
112.
Xiaolian Ye Gang Zou Jinxing Hou Huiru Bi Cuihua Zhou Runmin Wang Yun Xu Chun Wang Guiquan Chen Zhenyu Yin Jinping Zhang Chaoli Huang 《Biochemistry and Biophysics Reports》2020
Prolonged neuroinflammation is a driving force for neurodegenerative disease, and agents against inflammatory responses are regarded as potential treatment strategies. Here we aimed to evaluate the prevention effects on gliosis by dexamethasone (DEX), an anti-inflammation drug. We used DEX to treat the nicastrin conditional knockout (cKO) mouse, a neurodegenerative mouse model. DEX (10 mg/kg) was given to 2.5-month-old nicastrin cKO mice, which have not started to display neurodegeneration and gliosis, for 2 months. Immunohistochemistry (IHC) and Western blotting techniques were used to detect changes in neuroinflammatory responses. We found that activation of glial fibrillary acidic protein (GFAP) positive or ionized calcium binding adapter molecule1 (Iba1) positive cells was not inhibited in nicastrin cKO mice treated with DEX as compared to those treated with saline. These data suggest that DEX does not prevent or ameliorate gliosis in a neurodegenerative mouse model when given prior to neuronal or synaptic loss. 相似文献
113.
Paymaan Jafar-nejad Berit Powers Armand Soriano Hien Zhao Daniel A Norris John Matson Beatrice DeBrosse-Serra Jamie Watson Padmakumar Narayanan Seung
J Chun Curt Mazur Holly Kordasiewicz Eric E Swayze Frank Rigo 《Nucleic acids research》2021,49(2):657
Antisense oligonucleotides (ASOs) have emerged as a new class of drugs to treat a wide range of diseases, including neurological indications. Spinraza, an ASO that modulates splicing of SMN2 RNA, has shown profound disease modifying effects in Spinal Muscular Atrophy (SMA) patients, energizing efforts to develop ASOs for other neurological diseases. While SMA specifically affects spinal motor neurons, other neurological diseases affect different central nervous system (CNS) regions, neuronal and non-neuronal cells. Therefore, it is important to characterize ASO distribution and activity in all major CNS structures and cell types to have a better understanding of which neurological diseases are amenable to ASO therapy. Here we present for the first time the atlas of ASO distribution and activity in the CNS of mice, rats, and non-human primates (NHP), species commonly used in preclinical therapeutic development. Following central administration of an ASO to rodents, we observe widespread distribution and target RNA reduction throughout the CNS in neurons, oligodendrocytes, astrocytes and microglia. This is also the case in NHP, despite a larger CNS volume and more complex neuroarchitecture. Our results demonstrate that ASO drugs are well suited for treating a wide range of neurological diseases for which no effective treatments are available. 相似文献
114.
Farag Ola M. Abd-Elsalam Reham M. Ogaly Hanan A. Ali Sara E. El Badawy Shymaa A. Alsherbiny Muhammed A. Li Chun Guang Ahmed Kawkab A. 《Neurochemical research》2021,46(4):819-842
Neurochemical Research - Acrylamide (ACR) is an environmental pollutant with well-demonstrated neurotoxic and neurodegenerative effects in both humans and experimental animals. The present study... 相似文献
115.
116.
117.
118.
Ranganath Mamidi Joshua B. Holmes Chang Yoon Doh Katherine L. Dominic Nikhil Madugula Julian E. Stelzer 《The Journal of general physiology》2021,153(7)
Omecamtiv mecarbil (OM), a direct myosin motor activator, is currently being tested as a therapeutic replacement for conventional inotropes in heart failure (HF) patients. It is known that HF patients exhibit dysregulated β-adrenergic signaling and decreased cardiac myosin-binding protein C (cMyBPC) phosphorylation, a critical modulator of myocardial force generation. However, the functional effects of OM in conditions of altered cMyBPC phosphorylation have not been established. Here, we tested the effects of OM on force generation and cross-bridge (XB) kinetics using murine myocardial preparations isolated from wild-type (WT) hearts and from hearts expressing S273A, S282A, and S302A substitutions (SA) in the M domain, between the C1 and C2 domains of cMyBPC, which cannot be phosphorylated. At submaximal Ca2+ activations, OM-mediated force enhancements were less pronounced in SA than in WT myocardial preparations. Additionally, SA myocardial preparations lacked the dose-dependent increases in force that were observed in WT myocardial preparations. Following OM incubation, the basal differences in the rate of XB detachment (krel) between WT and SA myocardial preparations were abolished, suggesting that OM differentially affects the XB behavior when cMyBPC phosphorylation is reduced. Similarly, in myocardial preparations pretreated with protein kinase A to phosphorylate cMyBPC, incubation with OM significantly slowed krel in both the WT and SA myocardial preparations. Collectively, our data suggest there is a strong interplay between the effects of OM and XB behavior, such that it effectively uncouples the sarcomere from cMyBPC phosphorylation levels. Our findings imply that OM may significantly alter the in vivo cardiac response to β-adrenergic stimulation. 相似文献
119.
120.
ShuChun Kuo ChungChing Chio ChaoHung Yeh JuiTi Ma WenPin Liu MaoTsun Lin KaoChang Lin ChingPing Chang 《Aging cell》2021,20(5)
Amyloid‐beta (Aβ) oligomer is known to contribute to the pathophysiology of age‐related macular degeneration. Herein, we aimed to elucidate the in vivo and in vitro effects of Aβ1‐42 application on retinal morphology in rats. Our in vivo studies revealed that intracerebroventricular administration of Aβ1‐42 oligomer caused dysmorphological changes in both retinal ganglion cells and retinal pigment epithelium. In addition, in vitro studies revealed that ARPE‐19 cells following Aβ1‐42 oligomer application had decreased viability along with apoptosis and decreased expression of the tight junction proteins, increased expression of both phosphor‐AKT and phosphor‐GSK3β and decreased expression of both SIRT1 and β‐catenin. Application of conditioned medium (CM) obtained from mesenchymal stem cells (MSC) protected against Aβ1‐42 oligomer‐induced retinal pathology in both rats and ARPE‐19 cells. In order to explore the potential role of peptides secreted from the MSCs, we applied mass spectrometry to compare the peptidomics profiles of the MSC‐CM. Gene ontology enrichment analysis and String analysis were performed to explore the differentially expressed peptides by predicting the functions of their precursor proteins. Bioinformatics analysis showed that 3‐8 out of 155–163 proteins in the MSC‐CM maybe associated with SIRT1/pAKT/pGSK3β/β‐catenin, tight junction proteins, and apoptosis pathway. In particular, the secretomes information on the MSC‐CM may be helpful for the prevention and treatment of retinal pathology in age‐related macular degeneration. 相似文献